Short Description AVROBIO develops ex vivo lentiviral gene therapies to support healthy longevity.
Description AVROBIO is a biotechnology innovator targeting the fundamental mechanisms of aging through ex vivo lentiviral gene therapies. The company leverages advancements in gene therapy and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, AVROBIO aims to extend healthspan and improve quality of life across the globe.
Address 100 Technology Sq, Cambridge, MA, USA